Rewiring how advanced therapies are made

64x is an interdisciplinary team of scientists, engineers, and entrepreneurs on a mission to help next generation medicines reach the world. We’re combining our expertise in genetic engineering, cell line development, and computational biology, to create the foundation for scalable medicines.

We’re based in BRISBANE and Boston, with origins at Harvard University and the Wyss Institute for biologically inspired engineering. Join us if you’re ready to help build the future of advanced therapies.

Our Team

Lexi Rovner, PhD

CEO, Co-founder, Board of Directors](https://64xbio.com/team/lexi-rovner-phd)

George Church, PhD

Co-founder, Scientific Advisory Board](https://64xbio.com/team/george-church-phd)

David Thompson, PhD

Co-founder, Scientific Advisory Board](https://64xbio.com/team/david-thompson-phd)

Pamela Silver, PhD

Co-founder, Advisor](https://64xbio.com/team/pamela-silver-phd)

Jeffrey Way, PhD

Co-founder, Advisor](https://64xbio.com/team/jeffrey-way-phd)

Kareem Reda, MBA

Board of Directors, Advisor](https://64xbio.com/team/kareem-reda-mba)

Mathew T. Pletcher, PhD

Scientific Advisory Board](https://64xbio.com/team/mathew-t-pletcher-phd)

Stephen Sofen, PhD

Advisor](https://64xbio.com/team/stephen-sofen-phd)

Tim Smith, MBA

Advisor](https://64xbio.com/team/tim-smith-mba)

Grey Sieczkiewicz, JD, PhD

Advisor](https://64xbio.com/team/grey-sieczkiewicz-jd-phd)

Let’s build the infrastructure advanced therapies need

64x is rebuilding the foundation of manufacturing for next generation medicines. By enabling scale where it didn’t exist before, we’re on a mission to make transformative therapies accessible to the patients they were designed for.

General: info@64xbio.com

Licensing & Partnerships: bd@64xbio.com

biologics suite

Coming Soon

1000 Marina Blvd

Suite 100

Brisbane, CA 94005